Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$863.44K

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 10, 2026
Public filing date Jul 13, 2026
Filing lag Filed 3 days later

UTHR daily price context

Close on/before transaction
$547.06 Jul 10, 2026
First close after public filing
$526.66 Jul 14, 2026
30-day return after filing
-2.84% Through Aug 12, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
1,578 shares @ $547.17
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000096
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.46M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jul 10, 2026 $1.29M
United Therapeutics Corp UTHR Sale Jul 10, 2026 $324.22K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $525.23K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $1.01M
United Therapeutics Corp UTHR Sale Jul 10, 2026 $367.3K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $198.21K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $831.41K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $785.75K
United Therapeutics Corp UTHR Current Sale Jul 10, 2026 $863.44K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $219.38K
United Therapeutics Corp UTHR Sale Jul 10, 2026 $44.28K
United Therapeutics Corp UTHR Exercise Jul 10, 2026 $0